Publikationen

Beutter, C. N. L., Sigle, S., Martens, U., & Fegeler, C. (2021). Secondary use of sensor data from private wearables in medicine. Oncology Research and Treatment, 44(2), 302–303. https://doi.org/10.1159/000518417
Sigle, S., Kaufmes, K., Werner, P., Bochum, S., Martens, U., & Fegeler, C. (2021). Variant Browser: A comprehensive information retrieval tool for molecular genetics in a precision oncology setting. Oncology Research and Treatment, 44(2), 96–97. https://doi.org/10.1159/000518417
Sigle, S., Kaufmes, K., Werner, P., Bochum, S., Martens, U., & Fegeler, C. (2021). Introducing Variant Browser – a Meta Search Plattform for Genetic Variants. DocAbstr. 48. https://doi.org/10.3205/21gmds054
Sigle, S., Bochum, S., Werner, P., Walter, D., Martens, U. M., & Fegeler, C. (2020). Taming Data Sources to enable interoperable Clinical Decision Support for Virtual Molecular Tumor Boards. DGHO-Jahrestagung, Supplement Im Oncology Research and Treatment 2020, 69. https://doi.org/10.1159/isbn.978-3-318-06715-6
Beutter, C. N. L., Ross, J., Werner, P., Vladimirova, D., Martens, U. M., & Fegeler, C. (2020). Quality of life as an indicator for care delivery in clinical oncology using FHIR. Studies in Health Technology and Informatics, 110–117. https://doi.org/10.3233/SHTI210058
Sigle, S. (2020, November 17). Establishing Clinical Decision Support for Virtual Molecular Tumor Boards. FHIR Dev Days 2020. https://www.devdays.com/wp-content/uploads/2020/12/zibbw_201117_StefanSigle_Establishing_Clinical_Decision_Support_for_Virtual_Molecular_Tumor_Boards.pdf
Vladimirova, D., Bochum, S., Larribere, L., Kocher, S., Gallo, N., Sigle, S., Beutter, C. N. L., Biskup, S., Fegeler, C., & Martens, U. M. (2020). GASTRY: eine monozentrische Registerstudie zur Erfassung klinischer, molekularer und Lebensqualitätsparameter bei Patienten mit gastrointestinalen Tumoren / GASTRY: a monocentric registry study to record clinical, molecular and quality of life parameters in patients with gastrointestinal tumors. DGHO-Jahrestagung, Supplement Im Oncology Research and Treatment 2020. DGHO, Berlin. https://www.professionalabstracts.com/dgho2020/programme-dgho2020.pdf
Beutter, C. N. L., Sigle, S., Walter, D., Vladimirova, D., Martens, U. M., & Fegeler, C. (2020). Systematic approach to an automated, sensor-based collection of medical parameters in oncological care. DGHO-Jahrestagung, Supplement Im Oncology Research and Treatment 2020, 69. https://www.professionalabstracts.com/dgho2020/programme-dgho2020.pdf
Martens, U. M., Bochum, S., Mergel, F., Schiliro, A., Gallo, N., Pereira, P., Sipos, B., & Vladimirova, D. (2020). Rasches Therapieansprechen auf Larotrectinib bei mCRC-Patienten mit neuartiger onkogener NTRK-TP53 Fusion / Rapid clinical response to Larotrectinib in a mCRC patient with a novel oncogenic NTRK1-TP53 fusion. DGHO-Jahrestagung, Supplement Im Oncology Research and Treatment 2020, 133. https://www.professionalabstracts.com/dgho2020/programme-dgho2020.pdf
Bochum, S., Schall, L., Martens, U. M., Fegeler, C., & Pobiruchin, M. (2020). Pooling Clinical Cancer Registry Data with Public Genomic Datasets. Already an option to enhance real world evidence in precision oncology? DGHO-Jahrestagung, Supplement Im Oncology Research and Treatment 2020. DGHO. https://www.professionalabstracts.com/dgho2020/programme-dgho2020.pdf
Schall, L., Bochum, S., & Pobiruchin, M. (2020). Merging Genomics Public Datasets with Clinical Cancer Registry Data – Lessons Learned. GMDS.
Sigle, S., Werner, P., Bochum, S., Finkeisen, D., Martens, U. M., & Fegeler, C. (2020). Interoperable Knowledge- and Decision Support Components in Virtual Molecular Tumor Boards. GMDS.
Molekularpathologie on FHIR: Der Clinical Genomics Implementation Guide. (2020). DMEA – SParks.
Bochum, S. (n.d.). Platin-basierte Chemotherapeutika verlängern das Überleben von Pankreaskarzinom-Patienten mit einer Keimbahn-Mutation in BRCAness-Genen. Oncology Research and Treatment. https://doi.org/10.1159/000502425
Bochum, S., Vladimirova, D., Schiliro, A., Akkad, J., Autschbach, F., Finkeisen, D., Keil, A., Biskup, S., Fegeler, C., & Martens, U. M. (2019). Prolonged overall survival of pancreatic cancer patients with BRCAness germline mutations treated with DNA-damaging agents. Oncology Research and Treatment, 36. https://doi.org/10.1159/000502425
Keil, A., Sigle, S., Bochum, S., & Fegeler, C. (2019). Drowning in Information: The lack of integrating Knowledge Databases. Oncology Research and Treatment, 61. https://doi.org/10.1159/000502425
Beutter, C. N. L., Zsebedits, D., Ross, J., & Martens, U. M. (2019). Key factors for acceptance of an e-health solution. Oncology Research and Treatment, 61. https://doi.org/10.1159/000502425
Bochum, S., & Martens, U. M. (2019). Keimbahnmutationen können über Therapieerfolg entscheiden. JATROS Hämatologie & Onkologie. https://www.universimed.com/at/article/onkologie/keimbahnmutationen-koennen-ueber-therapieerfolg-entscheiden-2122385
Fegeler, C., Zsebedits, D., Bochum, S., Finkeisen, D., & Martens, U. M. (2018). Implementierung eines IT-gestützten molekularen Tumorboards in der Regelversorgung. Forum, 33(5), 322–328. https://doi.org/10.1007/s12312-018-0459-3
Berger, S., Bochum, S., Finkeisen, D., Schilliro, A., Autschbach, F., Bischof, M., Hagmueller, E., Pereira, P. L., Weickert, U., Sipos, B., Biskup, S., & Martens, U. M. (2018). Sustainable Response of a Patient With Metastasized Pancreatic Cancer and a Hypermutational Phenotype to Immunotherapy. New Therapeutic Concept for a Rare Subtype? JCO Precision Oncology, 2, 1–6. https://doi.org/10.1200/PO.18.00005
Werner, P. (2019). Semantical interoperability: precondition for modern big-data approaches. Oncology Research and Treatment, 61. https://doi.org/10.1159/000502425